The relationship between COMT and weight loss is a topic in nutrigenetics, but evidence is limited and mixed. COMT (catechol-O-methyltransferase) degrades catecholamines like dopamine and adrenaline. Variants such as Val158Met affect enzyme activity: the Met variant leads to slower breakdown, potentially increasing dopamine availability and possibly reducing appetite. Some studies suggest associations with BMI or energy expenditure, but effect sizes are small and not clinically actionable for personalized weight loss. Most commercial tests overstate the relevance. MyBody-X offers DNA tests, but specific COMT analysis for weight management is not validated in the provided context. Weight loss is primarily driven by calorie balance, exercise, and sleep. A genetic test may provide a minor insight but should not replace proven lifestyle interventions. Be cautious of marketing claims: no test can substitute a balanced diet and consistent habits.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-e90c2368229dc0e10a3acfce